Bernd Meibohm, associate dean for research and graduate programs and professor in the Department of Pharmaceutical Sciences at the University of Tennessee Health Science Center, had the findings of his latest research published in the February issue of biomedical sciences journal Nature Medicine. The article, titled “Spectinamides: a new class of semisynthetic antituberculosis agents that overcome… Read More
UTHSC In the Media
“Migraines cost our society billions of dollars a year,” said Memphis neurologist Dr. Stephen Landy… He is also a founding partner of Wesley Neurology Headache Clinic in Memphis and a Clinical Professor of Neurology at UT Health Science Center in Memphis.
Maria Gomes-Solecki, Assistant Professor, Microbiology, Immunology, and Biochemistry with UTHSC as well as President and CEO of Immunotechnologies, Inc., has worked to complete a field study that shows a vaccine for mice that helps fight Lyme disease in humans.
UT Medical Group has announced the opening of a new infertility service for would-be parent in the Mid-South. The center’s medical team is being led by Laura Detti, an associate professor of obstetrics and gynecology at the University of Tennessee Health Science Center and the only female board-certified reproductive endocrinologist in the Memphis market, according to UTMG.
To discuss the next steps for this novel mice vaccine technology, I am joined today … by US Biologic board director, Dr. Tom Monath, and the Cary Institute’s Dr. Rick Ostfeld, who led the field research in New York to test the efficacy of the vaccine (invented and produced by Dr. Maria Gomes-Solecki).
‘In 20 years, I would predict that we will know they’re safer than cigarettes, but they’re not safe.’ –Bob Klesges, Professor, University of Tennessee Health Science Center’s Department of Preventive Medicine
Dr. Wu, an assistant professor in the Department of Pathology and Laboratory Medicine at the University of Tennessee Health Science Center (UTHSC), is now being supported by a Research Scholar Grant, RSG-13-186-01-CSM, from the American Cancer Society. The four-year grant, which totals $720,000, will fund his study titled “Role of Genotoxic NF-kB Activation in Breast… Read More
… John Bissler, the new Chief of Pediatric Nephrology at Le Bonheur Children’s Hospital and a nationally known tuberous sclerosis (TS) expert … will also serve as director of Le Bonheur’s Tuberous Sclerosis Center of Excellence and a professor at theUniversity of Tennessee Health Science Center.